ECO 2026 12 - 15 May 2026

Time to sustainable weight reduction thresholds with semaglutide 7.2 mg in adults with obesity: A post hoc analysis of the STEP UP trial

Authors :

Georgia Argyrakopoulou1; Christine S. Fuchs Jacobsen2; Swathi Gopal3; Deborah. Horn4; Maria Quiroga5; John B. Buse6

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Keywords
Obesity
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)